StonvexLoading…
StonvexStonvexStonvexCore line items from FSTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $540.01M | $530.76M | $543.74M | $497.50M |
Operating Income | $21.89M | $20.51M | $9.11M | $-7.21M |
Net Income | $7.54M | $42.95M | $1.46M | $-45.56M |
EPS (Diluted) | $0.69 | $3.89 | $0.13 | $-4.25 |
Total Assets | $330.37M | $334.55M | $312.40M | $365.31M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.35M | $2.45M | $2.56M | $2.88M |
Free Cash Flow OCF − CapEx | $25.20M | $12.84M | $32.44M | $-18.21M |
Shares Outstanding | 10.14M | 10.57M | 10.73M | 10.78M |